Put lightly, it was less than a banner year for medical device and diagnostics companies looking to go public. Check out the report >>
Osprey Medical ($OSP) has reportedly caught the eye of investors with an auspicious beginning in its first day trading on the Australian Securities Exchange (ASX). It made its debut with a 5% premium listing at 42 cents, 2 cents above its issue price, The Australian notes.
Australia seems to be an increasingly popular spot for foreign devicemakers to raise funds through initial public offerings and subsequently list on that country's exchange. Following in the footsteps of GI Dynamics, U.S.-based Osprey Medical has raised $20 million Australian in its IPO and plans to list on the Australian Securities Exchange.